🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to individuals administering products of unknown origin.

Several professionals stated the popularity for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.

Several content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer laws, potentially leading to penalties, legal action or prison.

Platform Reaction and Content Removal

According to the social media company, the platform has removed problematic content and prohibited related keywords and query recommendations. The organization stated it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Digital Trading Activities

Research also found groups with up to 9,000 members marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of slimming results, positive reviews and step-by-step instructions for preparing or administering at home.

Within minutes of joining one community, a seller posted contact information, where the majority of transactions take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.

Item Information and Costs

Inside these groups, messages show black plastic packages with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how much time a injector should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram stated it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has already seen individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose patients to possibly serious health risks”.